Back to Results

Abattis Bioceuticals Corp (ATTBF)

Abattis Bioceuticals Corp. is a Canadian life sciences and biotechnology company listed on OTC Markets as common stock. The company focuses on developing and licensing natural health products, medicines, extracts, and ingredients for use in the biological, nutraceutical, bioceutical, and cosmetic sectors. Its business also includes Comfort, a cannabinoid-enhanced nutraceutical positioned for pain and inflammation, along with Health Canada-licensed services for the cannabis industry. Formerly known as Abattis Biologix Corporation, the company adopted its current name in September 2012. Incorporated in 1997, Abattis Bioceuticals Corp. is headquartered in Vancouver, Canada.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-ATTB.F
Not available
Not available
Not available
Good
0.0%
0.476 K
Valuation • Fair Value

Abattis Bioceuticals Corp (OTC-ATTB.F) Fair Value by Valuation Model

No usable valuation estimate is currently available for Abattis Bioceuticals Corp (OTC-ATTB.F); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Abattis Bioceuticals Corp (OTC-ATTB.F). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Abattis Bioceuticals Corp (OTC-ATTB.F)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Abattis Bioceuticals Corp (OTC-ATTB.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Abattis Bioceuticals Corp (OTC-ATTB.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Abattis Bioceuticals Corp (OTC-ATTB.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Abattis Bioceuticals Corp (OTC-ATTB.F)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Abattis Bioceuticals Corp (OTC-ATTB.F). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Abattis Bioceuticals Corp (OTC-ATTB.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Abattis Bioceuticals Corp (OTC-ATTB.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Abattis Bioceuticals Corp (OTC-ATTB.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Abattis Bioceuticals Corp (OTC-ATTB.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Abattis Bioceuticals Corp (OTC-ATTB.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Abattis Bioceuticals Corp (OTC-ATTB.F) Stock FAQ

Data-supported answers about Abattis Bioceuticals Corp (OTC-ATTB.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Good
Current financial-health read

A reliable fair value estimate is not currently available for Abattis Bioceuticals Corp (OTC-ATTB.F). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Abattis Bioceuticals Corp (OTC-ATTB.F) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Abattis Bioceuticals Corp (OTC-ATTB.F).

The current market capitalization listed for Abattis Bioceuticals Corp is 0.476 K.

The ticker symbol for Abattis Bioceuticals Corp is OTC-ATTB.F, and the stock is listed on OTC Markets.

Abattis Bioceuticals Corp (OTC-ATTB.F) is listed on OTC Markets.

Similar Pharmaceuticals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,135.1 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 635.8 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 358.4 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 294.8 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 172.3 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 171.2 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 125.6 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 101.5 B
SNY NASDAQ Sanofi ADR Fair Value Bargain Market Cap 99.408 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 65.044 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 45.924 B
HLN NYSE HALEON PLC ADR Fair Value Fair Market Cap 44.905 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 36.72 B
ZTS NYSE Zoetis Inc Fair Value Undervalued Market Cap 33.484 B
VTRS NASDAQ Viatris Inc Fair Value Fair Market Cap 20.675 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Fair Market Cap 13.892 B
ELAN NYSE Elanco Animal Health Fair Value Fair Market Cap 11.251 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 10.74 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Fair Market Cap 9.281 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Undervalued Market Cap 7.597 B